| Metric | Q3 2025 | Q2 2025 | Q3 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $51M | $50M | $34M | 1.3% | 49.4% |
| Op. Income | $19M | $15M | $9M | 26.9% | 101.0% |
| Gross Margin | 81.1% | 80.1% | 81.2% | 1.0pp | -0.1pp |
| Net Margin | 29.2% | 23.2% | 21.1% | 6.0pp | 8.1pp |
| EPS (Diluted) | $1.42 | $1.11 | $0.84 | 27.9% | 69.0% |
| Free Cash Flow | $23M | $18M | $13M | 26.9% | 70.8% |
| Item | Amount |
|---|---|
| REVENUE | $51M |
| Cost of Revenue | $10M |
| GROSS PROFIT | $41M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $14M |
| SG&A Expenses | $14M |
| Other Expenses | $9M |
| Operating Expenses | $22M |
| Cost & Expenses | $32M |
| OPERATING INCOME | $19M |
| Interest Income | $42M |
| Interest Expense | $10M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $19M |
| Income Tax Expense | $4M |
| Net Income from Continuing Ops | $15M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $15M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $15M |
| D&A | $2M |
| EBIT | $19M |
| EBITDA | $21M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $51M |
| Cost of Revenue | $10M |
| GROSS PROFIT | $41M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $14M |
| SG&A Expenses | $14M |
| Other Expenses | $9M |
| Operating Expenses | $22M |
| Cost & Expenses | $32M |
| OPERATING INCOME | $19M |
| Interest Income | $42M |
| Interest Expense | $10M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $19M |
| Income Tax Expense | $4M |
| Net Income from Continuing Ops | $15M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $15M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $15M |
| D&A | $2M |
| EBIT | $19M |
| EBITDA | $21M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $15M |
| Depreciation & Amortization | $2M |
| Stock-Based Compensation | $301.0K |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$2M |
| Change in Working Capital | $8M |
| OPERATING CASH FLOW | $23M |
| Capital Expenditure | -$430.0K |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$17M |
| Sales/Maturities of Investments | $16M |
| Other Investing Activities | $4M |
| NET CASH FROM INVESTING | $3M |
| Net Debt Issuance | $37M |
| Common Stock Repurchased | -$3M |
| Common Dividends Paid | -$4M |
| Other Financing Activities | -$59M |
| NET CASH FROM FINANCING | -$27M |
| FREE CASH FLOW | $23M |
| Net Change in Cash | -$970.0K |
| Item | Amount |
|---|---|
| Cash & Equivalents | $102M |
| Short-Term Investments | $462M |
| Net Receivables | $0 |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $564M |
| PP&E (Net) | $36M |
| Goodwill | $64M |
| Intangible Assets | $24M |
| Long-Term Investments | $2.4B |
| Tax Assets | $0 |
| Other Non-Current Assets | $168M |
| TOTAL NON-CURRENT ASSETS | $2.7B |
| TOTAL ASSETS | $3.3B |
| Account Payables | $0 |
| Short-Term Debt | $80M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $2.5B |
| TOTAL CURRENT LIABILITIES | $2.5B |
| Long-Term Debt | $255M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $36M |
| TOTAL NON-CURRENT LIABILITIES | $296M |
| TOTAL LIABILITIES | $2.8B |
| Common Stock | $28M |
| Additional Paid-In Capital | $179M |
| Retained Earnings | $250M |
| Treasury Stock | -$20M |
| Accum. Other Comp. Income | -$29M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $409M |
| Minority Interest | $0 |
| TOTAL EQUITY | $409M |
| TOTAL LIABILITIES & EQUITY | $3.3B |
| Total Debt | $341M |
| Net Debt | $238M |
